DongDong Tong

5PUBLICATIONS
5CO-AUTHORS
Regenerative medicine (incl. stem cells)Neural engineeringCancer diagnosisMedical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 08, 2026
MECP2 mutations disrupt pluripotent stem cell fate through remodeling of the three-dimensional genome.

|Oct 24, 2025
TRIM35, a novel DNA-binding protein, epigenetically modifies H3 to promote HSPA6 transcription and suppress breast cancer progression.

Xintao Jing, Fang Li, Jing Zhou

|Jun 18, 2024
AURKB/CDC37 complex promotes clear cell renal cell carcinoma progression via phosphorylating MYC and constituting an AURKB/E2F1-positive feedforward loop.

Fang Li, Xiaofei Wang, Jinyuan Zhang

|Nov 10, 2020
MiR-22, regulated by MeCP2, suppresses gastric cancer cell proliferation by inducing a deficiency in endogenous S-adenosylmethionine.

Dongdong Tong, Jing Zhang, Xiaofei Wang

|Jun 03, 2020
MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.

DongDong Tong, Jing Zhang, XiaoFei Wang

Pageof 1

Frequent Collaborators

3 joint publications

Chen Huang

2 joint publications

LingYu Zhao

2 joint publications

Chen Huang

1 joint publications

Xintao Jing